chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient received a dose of the vaccine following temperature excursions on unknown dates; No adverse event; This spontaneous report as received from a medical assistant refers to a current 5-month-old patient of unknown gender.  The patient's concurrent conditions, medical history and concomitant medications were not provided.   On an unknown date, the rotavirus vaccine, live, oral, pentavalent (ROTATEQ)  (lot # S013439 with expiration date 03-MAR-2021, lot # S013436 with expiration date 30-JAN-2021, and lot # S006050 with expiration date 12-DEC-2020) underwent a temperature excursion.   Temperature Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) Time frame 7 hours 30 minutes Previous temperature excursion? yes, Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) for 8 hours 30 minutes Was call because of a "data logger"? yes  On an unknown date, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) at a dose of 2 ml (route not provided) as prophylaxis. No adverse events were reported.  This is one of several reports received from the same reporter  This spontaneous report as received from a other health professional refers to a patient of unknown age.    On an unknown date the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # S006050, 2 milliliter for prophylaxis.       On an unknown date the patient experienced product storage error and no adverse event.    The outcome of product storage error and no adverse event is unknown.   The reporter considered product storage error and no adverse event to be not assessed to Rotavirus Vaccine, Live, Oral, Pentavalent(ROTATEQ).     {Additional information has been requested. / Additional information is not expected.}; Sender's Comments:  US-009507513-2005USA003382: US-009507513-2005USA004545: US-009507513-2005USA004950: US-009507513-2005USA004951: US-009507513-2005USA004952: US-009507513-2005USA004953: US-009507513-2005USA004954: US-009507513-2005USA004956: US-009507513-2005USA004957: US-009507513-2005USA004958: US-009507513-2005USA004959: US-009507513-2005USA004960: US-009507513-2005USA004961: US-009507513-2005USA004962: US-009507513-2005USA004963: US-009507513-2005USA004964: US-009507513-2005USA004965: US-009507513-2005USA004966: US-009507513-2005USA004967: US-009507513-2005USA004968: US-009507513-2005USA004969: US-009507513-2005USA004970: US-009507513-2005USA004971: US-009507513-2005USA004972: US-009507513-2005USA004973: US-009507513-2005USA004974: US-009507513-2005USA004975: US-009507513-2005USA004976: US-009507513-2005USA004977: US-009507513-2005USA004978: US-009507513-2005USA004979: US-009507513-2005USA004980: US-009507513-2005USA004981: US-009507513-2005USA004982: US-009507513-2005USA004983: US-009507513-2005USA004984: US-009507513-2005USA004985: US-009507513-2005USA004986: US-009507513-2005USA004987: US-009507513-2005USA004988: US-009507513-2005USA004989: US-009507513-2005USA004990: US-009507513-2005USA004991: US-009507513-2005USA004992: US-009507513-2005USA004993:
pretty sick; achiness; nausea; chills; slightly fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (pretty sick), MYALGIA (achiness), NAUSEA (nausea), CHILLS (chills) and PYREXIA (slightly fever) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 012A21A) for COVID-19 vaccination.     Concomitant products included VALACYCLOVIR [VALACICLOVIR] and SPIRONOLACTONE for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced ILLNESS (pretty sick), MYALGIA (achiness), NAUSEA (nausea), CHILLS (chills) and PYREXIA (slightly fever). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, ILLNESS (pretty sick), MYALGIA (achiness), NAUSEA (nausea), CHILLS (chills) and PYREXIA (slightly fever) was resolving.            This case was linked to MOD-2021-404394, MOD-2021-404423, MOD-2021-404534 (Patient Link).
pt recv vax SEP95 & lab eval revealed negative antibodies;no further details were provided;
5 days after 1st dose started to itch on torso - started to abate till got the 2nd shot- am still having itching issues; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 80-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EM9809, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 25Feb2021 at 13:45 pm (age at vaccination was 80 years) as dose 1, single for COVID-19 immunization. The patient's medical history included known allergies to sulfa and penicillin. The patient received concomitant medications or other medications within 2 weeks of vaccination. The patient previously took macrobid [nitrofurantoin] and experienced allergy. The facility where the most recent COVID-19 vaccine was administered was Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 02Mar2021, 5 days after 1st dose, the patient started to itch on torso. It started to abate till got the 2nd shot. The patient was still having itching issues. The adverse event resulted in Doctor or other healthcare professional office/clinic visit. The patient received treatment with topical creams. The patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6208, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 25Mar2021 (age at vaccination was unknown) as dose 2, single for COVID-19 immunization. The case was assessed as non-serious. The outcome of the event was not resolved.  No follow-up attempts are needed. No further information is expected.
Painful; Nightmares; Elevated Saturated Iron levels; Tired; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Painful), NIGHTMARE (Nightmares), HAEMOCHROMATOSIS (Elevated Saturated Iron levels), FATIGUE (Tired) and PYREXIA (Low grade fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), METOPROLOL, RALOXIFENE and SPIRONOLACTONE for an unknown indication.    On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Painful), NIGHTMARE (Nightmares), HAEMOCHROMATOSIS (Elevated Saturated Iron levels), FATIGUE (Tired) and PYREXIA (Low grade fever). At the time of the report, PAIN (Painful), NIGHTMARE (Nightmares), FATIGUE (Tired) and PYREXIA (Low grade fever) outcome was unknown and HAEMOCHROMATOSIS (Elevated Saturated Iron levels) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Serum ferritin: high (High) Elevated Ferritin levels. On an unknown date, Transferrin saturation: high (High) Elevated Saturated Iron levels.         Treatment information was not provided  The patient stated that, after receiving both the doses,  her ferritin and saturated iron levels have been elevated.  They are still elevated, but they have come down   This case was linked to MOD-2021-292460 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Aug-2021: Significant Follow up received on 19-AUG-2021 includes :Patient details,Concomitant Medication,Dosage date and events were updated.
Symptoms started 6/10/22. Diagnosed on 6/13/22. Treatment includes paxlovid. Hospitalized for sepsis.
Urinary tract infection; Arm pain; shivering; Legs were very weak/Very weak in the legs; had some shaking/shaky/arms and legs started shaking/tremor/whole body Shook for 10 mins then stopped after that worsening of shaking occured; Dizziness; Jerky; Forgetting everything; Would lose her balance; shaking woke her up; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Legs were very weak/Very weak in the legs), TREMOR (had some shaking/shaky/arms and legs started shaking/tremor/whole body Shook for 10 mins then stopped after that worsening of shaking occured), URINARY TRACT INFECTION (Urinary tract infection), DIZZINESS (Dizziness) and DYSKINESIA (Jerky) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037R21A and 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Post-traumatic stress disorder, Fibromyalgia, Peripheral neuropathy, Sciatica, Acid reflux (esophageal) and Pain in hip. Concomitant products included OMEPRAZOLE (ZEGERID [OMEPRAZOLE]) for Acid reflux (esophageal), GABAPENTIN, VALACYCLOVIR [VALACICLOVIR], ALPRAZOLAM, PRAVASTATIN, METOPROLOL, NALTREXONE, ALPRAZOLAM (XANAX) and VORTIOXETINE HYDROBROMIDE (TRINTELLIX) for an unknown indication.   On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In June 2021, the patient experienced MUSCULAR WEAKNESS (Legs were very weak/Very weak in the legs), TREMOR (had some shaking/shaky/arms and legs started shaking/tremor/whole body Shook for 10 mins then stopped after that worsening of shaking occured), DIZZINESS (Dizziness), DYSKINESIA (Jerky), MEMORY IMPAIRMENT (Forgetting everything), BALANCE DISORDER (Would lose her balance), SLEEP DISORDER (shaking woke her up) and CHILLS (shivering). On an unknown date, the patient experienced URINARY TRACT INFECTION (Urinary tract infection) and PAIN IN EXTREMITY (Arm pain). At the time of the report, MUSCULAR WEAKNESS (Legs were very weak/Very weak in the legs), URINARY TRACT INFECTION (Urinary tract infection), DIZZINESS (Dizziness), DYSKINESIA (Jerky), MEMORY IMPAIRMENT (Forgetting everything), BALANCE DISORDER (Would lose her balance), SLEEP DISORDER (shaking woke her up), PAIN IN EXTREMITY (Arm pain) and CHILLS (shivering) outcome was unknown and TREMOR (had some shaking/shaky/arms and legs started shaking/tremor/whole body Shook for 10 mins then stopped after that worsening of shaking occured) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging head: normal (normal) Normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Treatment medications were reported.   This case was linked to MOD-2021-348968 (Patient Link).
Pt complained of myalgias, fatigue, numbness and arthralgias post hep b vaccine. Symptoms' intensity increases over time. Also has sleep apnea. Diagnosed with chronic pain syndrome. ANNUAL FOLLOW UP STATES: Persistent anthralsias, myalsias, and fatigue.
This case was reported by a consumer via call center representative and described the occurrence of tiredness in a adult female patient who received SHINGRIX for prophylaxis. The patient's past medical history included shingles (at 18 years of age). In August 2018, the patient received the 1st dose of SHINGRIX. In August 2018, less than a day after receiving SHINGRIX, the patient experienced tiredness, pain and rash urticaria-like. On an unknown date, the outcome of the tiredness, pain and rash urticaria-like were recovered/resolved. It was unknown if the reporter considered the tiredness, pain and rash urticaria-like to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. Sometime in August 2018, the patient received SHINGRIX. After vaccination, the patient experienced tiredness, achiness and a hive-like rash on both her thighs. The reporter did not give consent to follow-up as she did not wish to be contacted.
Hives, itching, shortness of breath. Worsening of Psoriatic Arthritis pain and symptoms, skin warm to touch and painful all over body. Uveitis. Exacerbation of autoimmune symptoms.
PT WAS ADMINISTERED THE TDAP VACCINE (ADACEL) ON 4/16/07.  ON THE EVENING OF 4/26/07 SHE DEVELOPED A RASH ON HER TRUNK AND UPPER THIGHS, MIGRATORY JOINT PAIN AND WEAKNESS.  HER FAMILY PHYSICIAN STARTED HER ON A MEDROL DOSE PAK ON 4/28/07 AND REPORTS SHE FELT MUCH BETTER WITHIN TWO HOURS OF THE FIRST DOSE.  SYMPTOMS HAVE CONTINUED TO RESOLVE.
Information has been received from a physician, concerning a 49 year old female patient with breast cancer, who on 07-DEC-2007 was vaccinated, SQ, with the first dose, 0.5 mL, of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included tamoxifen citrate. On 08-DEC-2007, the patient developed redness and warmth at the injection site. The patient was examined in the office later that day, and the area of redness measured 6 cm but was resolving without requiring medical therapy. No further information was available. This is one of three reports from the same source. Additional information has been requested.
Couldn?t keep my eyes open. Several hot sweats even while taking Tylenol. It was very strange just like my neck couldn?t hold up my head and my eyes couldn?t stay open.
This spontaneous report was received from a licensed vocational nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of (Oka/Merck) VARIVAX (lot # L006386 with expiration date 25-FEB-2017; dose and route of administration were not reported). No adverse effects were reported. This is one several reports received from the same reporter. Additional information has been requested.
I had some arm pain that was I have an appointment next week on December 02, 2022, to see an orthopedic specialist. I felt like I have dislocated my shoulder. It feels like a torn rotator cuff. Its primary the shoulder. I have tried BIO FREEZE and over the counter aspirin, but it has not been affective.
next evening  experience pain on right side down near my kidney  floated up right side back and forth from liver to kidney  on 5th day experienced burning and slowly decreased till  the 8th day
Extreme swelling and pain in left arm to fingers and slight swelling in neck on same side. Also, complained of itching in area. Treated with cold compresses and Claritin.
9/30/13 c/o fever, achy, chills, SOB at noon - reported to Medical 10/1/13. Temp. 103.4 at 0924. Inmate give I.V. hydration, TYLENOL, supportive care. Inmate tested for Influenza. S/S lasted until 10/3/13 (fever). No documented fever 9/30/13 as inmate did not contact Medical.
pt recv vax 3MAR98 & tenderness, swelling noted 4MAR98 came to MD, 5MAR98 increased swelling, no response to  DPH;tx w/dicloxicillin for erythema, swelling, warmth;
This spontaneous report was received from a healthcare worker refers to male patient of approximately 1 year old. No information on concurrent conditions and medical history was reported. On 23-JUN-2015 the patient was vaccinated with improperly stored MMR II (unknown strength, route and dose) lot # K007107 with an expiry date of 16-MAY-2016, stored at improper temperature (< 46 degrees). Concomitant medications were not reported. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
In left flank area feels like a lump or mass on inside. Don't feel a lump topically but it feel (sensation) like something is there inwardly. With occasionally heaviness pain (dull). Also had flu like symptoms for a day and a half early August
Headache, facial burning (left side), stiff and painful neck, slight burning in throat, and elevated blood pressure.
Pt was vaccinated on 11/17/1997 and on 11/20/1997 she experienced rash around upper arm and a hard part on the under section of the arm. therapy with antibiotics wee started and the pt recovered. Subsequently, the pt's arm muscle had become weak and she has experienced arm pain. the pt has been attending physical therapy for this condition.
shingles; Information has been received from a lawyer regarding a case in litigation, concerning a 64-year-old female patient. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided. On 03-OCT-2017, the patient received a dose of Zoster Vaccine Live (ZOSTAVAX) (dosage information, lot number and expiration date were not provided) for its intended purpose: the prevention of shingles (herpes zoster). Subsequently in November 2017, the patient suffered shingles, including any and all of its sequelae.  As a result of the receipt of the vaccination, the patient experienced sustained severe and permanent personal injuries, as well as significant pain, suffering, and emotional distress. The reporter considered the event of shingles to be related to suspect therapy. At the time of the report, the patient's outcome was not recovered.  Upon internal review, shingles was considered a disabling event.
approximately 22 hours after receiving vaccine I started with onset nausea, malaise, joint pain, chills. This continued through the week but I had severe intermittent joint pain 8 /10 on pain scale (crying) , I was close to going in but like to tough it out since I am RN and know already nothing would be done especially with the von willanbrands, currently today I have the nausea, malaise and continued joint pain just not as severe. I regret getting the vaccine.
Sore arm on day of injection (11/05/12). Woke up next morning (11/06/12) with body aches & headache, neck & shoulder pain, severe pain at injection site. Fatigued and weak all day. Rigors started around 4:30 PM. Fever of 101 degrees at 8:00 PM. On day 3 (11/07/12), significant pain at injection site persists, but fever has subsided.
This spontaneous report was received from a nurse reporting from the doctor's office, via company representative, on behalf of the patient's mother, concerning a 24 year old female patient. The patient's historical condition, concurrent condition and concomitant therapy were unknown. On an unknown date, also reported as "years ago", at an unspecified age, the patient was vaccinated with GARDASIL  (strength, dose, route, frequency, lot# and expiration date were not reported) for prophylaxis. She received all 3 doses (unspecified dates). According to the patient's mother, the patient experienced a moody personality (not specified). On an unknown date in 2018, reported as "recently", the patient received the 1 dose of GARDASIL 9 (strength, dose, route, frequency, lot# and expiration date indication were not reported) for prophylaxis. On an unknown date in 2018, the patient's mother reported that she believed that her daughter experienced personality change after receiving GARDASIL 9, which she described as "moody". No hospitalization was required and no treatment was given for the events. It was unknown if the event presented a significant disability or incapacity, if laboratory diagnostics-studies were performed or if the patient sought for medical attention. The adverse event was not cancer and the patient did not overdosed. At the time of reporting, the outcome of personality change and moody was not recovered. Additionally, the causality assessment between GARDASIL 9 and the aforementioned event was not reported.
Information has been received from a physician concerning his 71 year old wife with no known allergies and no pertinent medical history who on 19-DEC-2008 was vaccinated with a dose of ZOSTAVAX. Concomitant therapy included CRESTOR. On approximately 22-DEC-2008 the patient experienced pain on the upper left arm at the injection site. The pain was getting a lot worse and radiated from the left upper arm to the back to the shoulder and neck. The physician considered the pain on the upper left arm at the injection site radiating to the back, shoulder and neck were considered to be disabling because the patient couldn't sleep and the area was very sensitive. Additional information has been requested.
pt recv vax 24JAN97 & 28MAR97 pt exp rash & fever;according to pt mom it was a very bad case;
20 yo trainee developed URI and chest pain 2 weeks after immunizations.  Chest pain intermittent and resolved in a few weeks, but returned on 5/1/2012 to constant, band--like pain in left upper chest, 6/10, increased with exertion. 2 ED visits, clinic visits.
Pain in armpit of vaccinated arm; This is a spontaneous report received from a non-contactable reporter (Pharmacist). The reporter is the patient.  A 43-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm right, administration date 24Apr2021 at 11:15 (Batch/Lot number: unknown) at the age of 43 years as dose 1, single for COVID-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: intravenous (IV) morphine, reaction(s): "Itching", notes: IV Morphine. The following information was reported: AXILLARY PAIN (non-serious) with onset 25Apr2021, outcome "not recovered", described as "Pain in armpit of vaccinated arm". Therapeutic measures were not taken as a result of axillary pain.  Additional information: The patient received the vaccine in the right upper arm (shoulder). The patient had not been diagnosed with COVID-19 prior to vaccination and had not testes for COVID-19 post vaccination. The patient had no other relevant medical history a part from the itching with IV morphine.  No follow-up attempts are possible. No further information is expected.
I am the patient's neurologist. The patient has very well controlled epilepsy without a seizure in over a year. He is compliant with medication and did not have another provoking factor.  Approximately 6 hours after receiving the vaccine he had a generalized seizure, which was witnessed by his wife. He had an aura, behavioral arrest, tonic-clonic activity for 1 minute followed by a post-ictal period of several hours. This is consistent with his known seizures, but the provocation appears to be the vaccine he received earlier in the day.
patient called at around 5:15pm on 3/8/21 reporting that she has developed swelling around her right eyes after 1:30pm today (3/8). She received the COVID-19 vaccine yesterday around 10:15am. Patient mentioned that she had some headache and injection site soreness and pain after receving the vaccine, but was fine until today when the swelling appears. She reported no pain with her swollen eyes. Suggested patient to reach out to her PCP or see a doctor in the emergency room.
Moderna Covid-19  Lot# 011L20A  Tingling to entire face  within 15-30 minutes of receiving vaccine.  Had to take Benadryl 50mg at home in order to relieve symptoms.  Symptoms returned after Benadryl wore off and had to take an additional dose.  Symptoms resolved completely after 24 hours
Red, warm, swelling, pain, numbness to site. Some short of breath. Went to Urgent Care for treatment. Benadryl. Still pain, numbness this morning but somewhat better.
Well on the first of September I started getting a pain in my stomach and I would lay down and it would go away. So I went to the ER and then they did some imaging and found out I had appendicitis.